Included in its impressive line-up is the Collagen Jelly Cream that is said to reveal that 'glass-skin glow'. Described as a ...
In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
A PLAYBOY bunny who almost died after getting the same back-street Brazilian Bum Lift that is feared to have killed the “Lip ...
MoneyWeek on MSN
Invest in the beauty industry as it takes on a new look
The beauty industry is proving resilient in troubled times, helped by its ability to shape new trends, says Maryam Cockar ...
The term "high-maintenance" comes with negative connotation, but it really just means looking polished is an investment. Here's how much one editor actually spends.
While he is ferried around in an armored Cadillac believed to weigh 10 tons and nicknamed “the beast,” Trump expressed delight on Wednesday with Japan’s pint-sized kei cars, deeming them “really cute” ...
TORONTO—AbbVie, the global pharmaceutical company behind Botox, has confirmed to Animal Justice that it’s stopped using animal-based testing for every batch of its anti-wrinkle products destined for ...
Most women I know currently have or at some point have undergone some sort of cosmetic procedure. Botox, filler, injectables. Veneers, a nose job. In 2026, it’s common — nay, expected — for women to ...
Thrifty Jinxy on MSN
10 wellness trends that drain your HSA fast
HSAs are meant for qualified medical expenses-things that diagnose, treat, or prevent a real health condition under IRS rules. Cosmetic treatments and general "feel better" programs usually don't ...
17hon MSN
Cheaper, easier and less taboo: Why more gen Zs are getting cosmetic injectables such as botox
The number of non-surgical cosmetic procedures such as botox has increased by more than 44 per cent worldwide in four years.
Garner opened up about her past tweaks and potential future procedures while speaking with Kylie Kelce on her 'Not Gonna Lie' ...
As the market digests Big Tech’s ambitious artificial-intelligence spending plans for 2026, the relative cheapness of Microsoft’s stock underscores a new dichotomy in technology investing. Microsoft’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results